-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$11.14197.86% Upside
Recent Analyst Forecasts and Stock Ratings
Sutro Biopharma, Inc. Frequently Asked Questions
-
What analysts cover Sutro Biopharma, Inc.?
Sutro Biopharma, Inc. has been rated by research analysts at Bank of America Securities, H.C. Wainwright, Truist Financial, Deutsche Bank, Wedbush, Oppenheimer in the past 90 days.